Hepatosplenic T cell lymphoma epidemiology and demographics
|
Hepatosplenic T cell lymphoma Microchapters |
|
Differentiating Hepatosplenic T cell lymphoma from other Diseases |
|---|
|
Diagnosis |
|
Treatment |
|
Case Studies |
|
Hepatosplenic T cell lymphoma epidemiology and demographics On the Web |
|
American Roentgen Ray Society Images of Hepatosplenic T cell lymphoma epidemiology and demographics |
|
FDA on Hepatosplenic T cell lymphoma epidemiology and demographics |
|
CDC on Hepatosplenic T cell lymphoma epidemiology and demographics |
|
Hepatosplenic T cell lymphoma epidemiology and demographics in the news |
|
Blogs on Hepatosplenic T cell lymphoma epidemiology and demographics |
|
Directions to Hospitals Treating Hepatosplenic T cell lymphoma |
|
Risk calculators and risk factors for Hepatosplenic T cell lymphoma epidemiology and demographics |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Sowminya Arikapudi, M.B,B.S. [2]
Overview
Hepatosplenic T cell lymphoma is a common disease that tends to affect young adults and adolescents. Males are more commonly affected with hepatosplenic T cell lymphoma than females.[1]
Epidemiology and Demographics
Age
Hepatosplenic T cell lymphoma is a common disease that tends to affect young adults and adolescents.[1]
Gender
Males are more commonly affected with hepatosplenic T cell lymphoma than females.[1]
References
- ↑ 1.0 1.1 1.2 Hepatosplenic T cell lymphoma. Surveillance, Epidemiology, and End Results Program. http://seer.cancer.gov/seertools/hemelymph/51f6cf56e3e27c3994bd52ee/. Accessed on February 22, 2016